IGC Pharma (IGC) Enterprise Value Growth (1y) (2011 - 2026)
IGC Pharma (IGC) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
IGC Pharma |
29.33 Mn |
29.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
35.06% |
| Dec 31, 2025 |
-107.66% |
| Sep 30, 2025 |
25.29% |
| Jun 30, 2025 |
75.11% |
| Mar 31, 2025 |
66.19% |
| Dec 31, 2024 |
65.89% |
| Sep 30, 2024 |
50.51% |
| Jun 30, 2024 |
16.21% |
| Mar 31, 2024 |
65.81% |
| Dec 31, 2023 |
73.09% |
| Sep 30, 2023 |
54.17% |
| Jun 30, 2023 |
72.97% |
| Mar 31, 2023 |
66.50% |
| Dec 31, 2022 |
57.11% |
| Sep 30, 2022 |
52.66% |
| Jun 30, 2022 |
39.54% |
| Mar 31, 2022 |
28.49% |
| Dec 31, 2021 |
-302.32% |
| Sep 30, 2021 |
-187.92% |
| Jun 30, 2021 |
-70.73% |
